Swiss drugmaker Roche is breaking into hemophilia A treatment, a $10 billion (£7.70 billion) global market dominated by rivals who have cultivated close ties to sufferers of the genetic bleeding disorder.
UK: With Hemlibra, Roche seeks to break into tight hemophilia circle
![UK: With Hemlibra, Roche seeks to break into tight hemophilia circle]()
Reviewed by Shahid Karimi
on
October 03, 2018
Rating:
No comments: